Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SCH 27899

Known as: SCH-27899 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

evernimicin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial.
The antimicrobial activity of evernimicin (formerly SCH 27899), a novel oligosaccharide antimicrobial of the everninomicin class… Expand
  • table I
  • table II
  • table III
  • table IV
2001
2001
In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis
ABSTRACT Currently, there exist few satisfactory alternatives to vancomycin for therapy of serious methicillin-resistant… Expand
  • figure 1
  • figure 2
Highly Cited
2000
Highly Cited
2000
Evernimicin Binds Exclusively to the 50S Ribosomal Subunit and Inhibits Translation in Cell-Free Systems Derived from both Gram-Positive and Gram-Negative Bacteria
ABSTRACT Evernimicin (SCH 27899) is a new antibiotic with activity against a wide spectrum of gram-positive bacteria and activity… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
2000
2000
Pharmacokinetics of an Everninomicin (SCH 27899) in Mice, Rats, Rabbits, and Cynomolgus Monkeys following Intravenous Administration
ABSTRACT The pharmacokinetics of SCH 27899, a novel oligosaccharide compound of the everninomicin class with excellent activity… Expand
  • figure 1
  • figure 4
  • figure 2
  • figure 3
  • table 1
1999
1999
In Vitro Activities of the Everninomicin SCH 27899 and Other Newer Antimicrobial Agents against Borrelia burgdorferi
ABSTRACT The in vitro activity of the everninomicin antibiotic SCH 27899 against 17 isolates of Borrelia spp. was investigated… Expand
1999
1999
In vitro activity of SCH 27899 (Ziracin) against Legionella species.
The activities of Sch 27899 (Ziracin), erythromycin, and ofloxacin against 102 Legionella spp. isolates were measured by a… Expand
Highly Cited
1998
Highly Cited
1998
Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals…
  • F. Aarestrup
  • Microbial drug resistance
  • 1998
    • Corpus ID: 24325670
The emergence of multiresistant bacteria has increased the need for new antibiotics or modifications of older antibiotics. One… Expand
Highly Cited
1997
Highly Cited
1997
Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?
The widespread appearance of methicillin resistant Staphylococcus aureus (MRSA) has significantly undermined the efficacy of… Expand
1996
1996
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin.
The antibacterial activity of SCH 27899, was compared with vancomycin in vitro against 210 recent clinical isolates representing… Expand
1995
1995
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum.
The in vitro antimicrobial activity of SCH 27899 (everninomycin), a novel oligosaccharide compound of the everninomycin class… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE